SOBRsafe Inc. Secures European Patent for Innovative Alcohol Detection Technology

SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in cutting-edge alcohol monitoring solutions, has recently achieved a milestone with the European Patent Office granting European Patent No. EP4171362 for its SOBRcheck(TM) device. This patent underscores the company's innovative approach to alcohol detection, utilizing a noninvasive transdermal system that combines skin-contact verification, biometric ID scanning, and wireless data transmission to identify alcohol consumption without the need for breath, blood, or urine samples.

The significance of this patent cannot be overstated, as it solidifies SOBRsafe's foothold in critical sectors such as workplace safety, judicial compliance, and wellness programs. The technology's ability to provide real-time, passive screening offers a dignified alternative to traditional methods, potentially transforming how alcohol consumption is monitored across various industries. With planned European pilot programs slated for the second half of 2025, the patent paves the way for SOBRsafe's expansion into new markets.

For those interested in learning more about SOBRsafe and its groundbreaking technology, additional information can be found at https://www.sobrsafe.com. Meanwhile, investors and stakeholders looking for the latest updates on SOBRsafe can visit the company's newsroom at https://ibn.fm/SOBR.

This development represents a leap forward in alcohol detection technology, offering a seamless, efficient, and less intrusive method for ensuring safety and compliance. As SOBRsafe continues to innovate and expand its reach, the implications for public health and safety are profound, setting a new standard for alcohol monitoring worldwide.